Age-specific differences in the treatment of cervical cancer in the east and the south of The Netherlands 1989-2004

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 147, Issue 1, 2009, Pages 78-82

  van der Aa, Maaike A ^a   Siesling, Sabine ^a   Poll Franse, Lonneke V v d ^b   Schutter, Eltjo M ^c   Lybeert, Marnix L ^d   Coebergh, Jan Willem W ^b,e  

^a Integraal Kankercentrum Noord Nederland   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cervical cancer; Chemoradiation; Hysterectomy; Radiotherapy; Survival

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEATH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX CANCER;

EID: 72049129685     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.07.006     Document Type: Article

References (23)

1. Yamashita H., Nakagawa K., Tago M., et al. Comparison between conventional surgery and radiotherapy for FIGO stage I-II cervical carcinoma: a retrospective Japanese study. Gynecol Oncol 97 (2005) 834-839
2. van der Velden J., Samlal R., Schilthuis M.S., Gonzalez D.G., ten Kate F.J., and Lammes F.B. A limited role for adjuvant radiotherapy after the Wertheim/Okabayashi radical hysterectomy for cervical cancer confined to the cervix. Gynecol Oncol 75 (1999) 233-237
3. Trimbos J.B. Gynaecologische Oncologieklapper. 2nd ed. (1995), Working Group for Gynecological Oncology, Leiden, The Netherlands
4. Work Group Oncologic Gynaecology. www.oncoline.nl.
5. Ryu H.S., Chun M., Chang K.H., Chang H.J., and Lee J.P. Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients. Gynecol Oncol 96 (2005) 490-495
6. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
7. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
8. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17 (1999) 1339-1348
9. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1161
10. Peters III W.A., Liu P.Y., Barrett R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
11. van der Zee J., and Gonzalez G.D. The Dutch Deep Hyperthermia Trial: results in cervical cancer. Int J Hyperthermia 18 (2002) 1-12
12. Hanselaar A.G. Criteria for organized cervical screening programs special emphasis on The Netherlands program. Acta Cytol 46 (2002) 619-629
13. Ederer F, Heise H. Instructions to IBM 6500 programmers in processing survival computations. Methodological note no. 10, End Results Evaluation Section. Bethesda MD: National Cancer Institute; 1959.
14. Abayomi J., Kirwan J., Hackett A., and Bagnall G. A study to investigate women's experiences of radiation enteritis following radiotherapy for cervical cancer. J Hum Nutr Diet 18 (2005) 353-363
15. Hawighorst-Knapstein S., Fusshoeller C., Franz C., et al. The impact of treatment for genital cancer on quality of life and body image-results of a prospective longitudinal 10-year study. Gynecol Oncol 94 (2004) 398-403
16. Jensen P.T., Groenvold M., Klee M.C., Thranov I., Petersen M.A., and Machin D. Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 56 (2003) 937-949
17. Schouten L.J., Langendijk J.A., Jager J.J., and van den Brandt P.A. Validity of the stage of lung cancer in records of the Maastricht cancer registry, The Netherlands. Lung Cancer 17 (1997) 115-122
18. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358 (2001) 781-786
19. Goodheart M., Jacobson G., Smith B.J., and Zhou L. Chemoradiation for invasive cervical cancer in elderly patients: outcomes and morbidity. Int J Gynecol Cancer (2007)
20. Wright J.D., Gibb R.K., Geevarghese S., et al. Cervical carcinoma in the elderly: an analysis of patterns of care and outcome. Cancer 103 (2005) 85-91
21. Yellen S.B., Cella D.F., and Leslie W.T. Age and clinical decision making in oncology patients. J Natl Cancer Inst 86 (1994) 1766-1770
22. Newcomb P.A., and Carbone P.P. Cancer treatment and age: patient perspectives. J Natl Cancer Inst 85 (1993) 1580-1584
23. Signaleringscommissie Kanker van KWF Kankerbestrijding. Kanker in Nederland; Trends, prognoses en implicaties voor zorgvraag. Oisterwijk: Drukkerij van den Boogaard; 2004.